Ambulatory Treatments of Covid-19
Publication Title
Providence Grand Rounds
Document Type
Presentation
Publication Date
1-11-2022
Keywords
covid-19; washington; everett
Abstract
Dr. Diaz became an important leader in the COVID-19 pandemic by treating “patient zero,” the first known patient to be hospitalized with symptoms of the novel coronavirus in the United States. He enrolled this first patient and 139 more in clinical trials testing the use of the antiviral drug remdesivir. Diaz was the principal investigator for clinical trials with remdesivir and author on three articles published in the New England Journal of Medicine: “This drug is now part of the standard of care for treatment of patients with COVID-19 pneumonia in the U.S," Diaz said.
Providence-WSU Internal Medicine Residency Center 1321 Colby Avenue, Suite B400 Everett, WA 98201
The Seattle Science Foundation is a not for profit organization dedicated to advancing the quality of patient care through education, research, innovation and technology. As a physician driven organization, we have created a trusted community of nationally recognized experts from the world’s best medical and academic institutions.
SSFTV is the official YouTube channel of the Seattle Science Foundation. Subscribe now to be updated on the latest videos: tinyurl.com/yt8kt8mg.
Specialty/Research Institute
Infectious Diseases
Specialty/Research Institute
Hospital Medicine
